Recursion Pharmaceuticals, Inc. (RXRX)
2.45
-0.27
(-9.93%)
USD |
NASDAQ |
Nov 20, 16:00
2.50
+0.05
(+2.04%)
After-Hours: 20:00
Recursion Pharmaceuticals Total Assets (Quarterly) : 1.222B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.222B |
| June 30, 2026 | 1.213B |
| March 31, 2026 | 1.340B |
| December 31, 2025 | 1.528B |
| September 30, 2025 | 1.400B |
| June 30, 2025 | 1.302B |
| March 31, 2025 | 1.305B |
| December 31, 2024 | 1.449B |
| September 30, 2024 | 726.50M |
| June 30, 2024 | 775.86M |
| March 31, 2024 | 557.85M |
| December 31, 2023 | 653.70M |
| Date | Value |
|---|---|
| September 30, 2023 | 630.82M |
| June 30, 2023 | 666.70M |
| March 31, 2023 | 627.37M |
| December 31, 2022 | 701.29M |
| September 30, 2022 | 611.53M |
| June 30, 2022 | 672.52M |
| March 31, 2022 | 734.32M |
| December 31, 2021 | 610.34M |
| September 30, 2021 | 658.61M |
| June 30, 2021 | 698.59M |
| March 31, 2021 | 271.94M |
| December 31, 2020 | 298.58M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| AbbVie, Inc. | 147.68B |
| Amgen, Inc. | 96.05B |
| Halozyme Therapeutics, Inc. | 3.473B |
| Neurocrine Biosciences, Inc. | 5.627B |
| AVITA Medical, Inc. | 46.79M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 315.90M |
| Shareholders Equity (Quarterly) | 905.81M |
| Debt to Equity Ratio | 0.0825 |
| Current Ratio | 5.012 |
| Net Debt Paydown Yield | 0.12% |